McShane Emma, Hanna Lauren, Zoanetti Carmel, Murnane Lisa, Baguley Brenton, Furness Kate
Department of Sport, Exercise and Nutrition Sciences, School of Allied Health, Human Services and Sport, La Trobe University, Bundoora, VIC 3086, Australia.
Nutrition & Dietetics Department, Alfred Health, Melbourne, VIC 3004, Australia.
Nutrients. 2025 Aug 20;17(16):2691. doi: 10.3390/nu17162691.
: Gastric, oesophageal, and pancreatic cancers are common worldwide, with low but improving survival rates due to advances in curative treatments. However, these treatments often cause long-term nutrition impact symptoms that are frequently overlooked, leading to malnutrition and poorer health outcomes. This review explored the types of nutrition impact symptoms following curative-intent treatment for upper gastrointestinal (UGI) cancers and assessed their impact on nutrition status. A systematic search of four electronic databases identified studies involving adults treated with curative intent for UGI cancers. Included studies reported both nutrition impact symptoms and nutrition outcomes using validated tools. Study quality was assessed, and results were synthesised narratively. Eleven studies (n = 953 participants), predominantly from the Asia-Pacific region, met the inclusion criteria. Participants were mostly male (68%), with surgery as the primary treatment (91%). Most studies (n = 10) used validated assessment tools to identify nutrition impact symptoms. Reflux was the most commonly reported symptom (n = eight studies), followed by abdominal pain and diarrhoea. Nutrition status was assessed using various validated tools: Patient-Generated Subjective Global Assessment (n = six studies, 55%), Mini Nutritional Assessment (n = two studies, 18%), and Global Leadership Initiative on Malnutrition as well as Subjective Global Assessment and Prognostic Nutritional Index (both n = one study, 9%). Malnutrition prevalence was up to 87% one year post-treatment. Nutrition impact symptoms are common and persistent after curative-intent treatment for UGI cancers. Future research should incorporate validated assessment tools and extend follow-up beyond 12 months. Integrating long-term, tailored dietetic support to identify and manage symptoms post-treatment is vital to improve outcomes for patients.
胃癌、食管癌和胰腺癌在全球范围内都很常见,由于根治性治疗的进展,生存率虽低但有所提高。然而,这些治疗常常会引发长期的营养影响症状,而这些症状经常被忽视,从而导致营养不良和更差的健康结果。本综述探讨了上消化道(UGI)癌根治性治疗后的营养影响症状类型,并评估了它们对营养状况的影响。对四个电子数据库进行系统检索,确定了涉及接受UGI癌根治性治疗的成年人的研究。纳入的研究使用经过验证的工具报告了营养影响症状和营养结果。评估了研究质量,并对结果进行了叙述性综合分析。11项研究(n = 953名参与者)符合纳入标准,这些研究主要来自亚太地区。参与者大多为男性(68%),主要治疗方式为手术(91%)。大多数研究(n = 10)使用经过验证的评估工具来识别营养影响症状。反流是最常报告的症状(n = 8项研究),其次是腹痛和腹泻。使用各种经过验证的工具评估营养状况:患者自评主观全面评定法(n = 6项研究,55%)、微型营养评定法(n = 2项研究,18%)、全球营养不良领导倡议以及主观全面评定法和预后营养指数(均为n = 1项研究,9%)。治疗后一年营养不良患病率高达87%。UGI癌根治性治疗后,营养影响症状常见且持续存在。未来的研究应纳入经过验证的评估工具,并将随访时间延长至12个月以上。整合长期、个性化的饮食支持以识别和管理治疗后的症状对于改善患者预后至关重要。